Chronos Therapeutics Ltd

Europe Legal Chronicle. April 5, 2024

Evgen Pharma Plc’s £3.4 Million Acquisition of Majority Stake in Chronos Therapeutics Ltd

By Marco Zingaro

Clyde & Co advised Chronos Therapeutics Limited on the deal. Evgen Pharma plc (AIM:EVG) agreed to acquire Chronos Therapeutics Ltd. for £3.4 million. The total consideration...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Tex-Tech Industries’ $165 Million Acquisition of Fiber Materials

Outbuild’s $11 Million Series A Financing Round

GSR III Acquisition Corp.’s US$200 Million Initial Public Offering

TuSueldoYa’s Capital Increase

‘Mercado Crédito XXIX’ Financial Trusts’s US$43 Million Issuance

YPF Luz’s US$420 Million Notes Issuance

BIT ODD’s €17 Million Equity Round

Peach Property Group’s Divestment of Residential Portfolio

Mutares’ Acquisition of VR Road Logistics

Saudi Egyptian Developers’ EGP4.35 Billion Syndicated Loan

Tamweely’s EGP 5 Billion Securitization Program

TE H2, CIP, and A.P. Moller Capital’s Developmente Of Large-Scale Green Hydrogen Project In Morocco

Taaleem Holdings’ Acquisition of Lycée Libanais Francophone Privé Meydan School

Commercial Bank of Dubai’s US$500 Million Bond Issuance

Medianova’s Investment Round

Firstsource Solutions UK Limited’s £42 Million Acquisition Of Ascensos Limited

Cathay Pacific Airways Ltd’s HK$6.732 Billion Convertible Bonds Issuance

China Water Affairs Group Limited’s HK$361 Million Exchangeable Bonds Offering

King & Spalding Continues Antitrust Growth with Addition of Partner Olivier N. Antoine in New York

Real Estate Partner Brian Crist Joins Barnes & Thornburg

Paul, Weiss Welcomes Two Leading Life Science & Technology Litigators in New York

The Diarra Ruling On The Transfer Of Players Within The EU And The FIFA Regulation On The Status And Transfer Of Players

The Distinctive Character Of The ‘Vespa’ Is No Longer In Question

Cultural Heritage Sites With Restrictions On Intended Use: The Council of State Acknowledges That This Power Lies In the Hands Of The Ministry Of Culture

King & Spalding Continues Antitrust Growth with Addition of Partner Olivier N. Antoine in New York

Real Estate Partner Brian Crist Joins Barnes & Thornburg

Paul, Weiss Welcomes Two Leading Life Science & Technology Litigators in New York

Evgen Pharma Plc’s £3.4 Million Acquisition of Majority Stake in Chronos Therapeutics Ltd

Standard 1 Year Membership Required